For: | Xu JX, Wu DH, Ying LW, Hu HG. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification. World J Gastroenterol 2021; 27(47): 8123-8137 [PMID: 35068858 DOI: 10.3748/wjg.v27.i47.8123] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v27/i47/8123.htm |
Number | Citing Articles |
1 |
Efstathios Theodoros Pavlidis, Theodoros Efstathios Pavlidis. Molecular factors, diagnosis and management of gastrointestinal tract neuroendocrine tumors: An update. World Journal of Clinical Cases 2022; 10(27): 9573-9587 doi: 10.12998/wjcc.v10.i27.9573
Abstract(81) |
Core Tip(66) |
Full Article(HTML)(815)
|
Full Article (PDF)-769K(149)
|
Full Article (Word)-201K(30)
|
Audio-381K(2)
|
Peer-Review Report-516K(13)
|
Answering Reviewers-444K(14)
|
Times Cited (0)
|
Total Visits (1388)
|
Open
|
2 |
Jim Smith, Edward Barnett, Euan J. Rodger, Aniruddha Chatterjee, Rathan M. Subramaniam. Neuroendocrine Neoplasms. PET Clinics 2023; 18(2): 169 doi: 10.1016/j.cpet.2022.11.003
|